{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:34:46Z","timestamp":1791362086063,"version":"4.3.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2704200"],"award-info":[{"award-number":["2022YFC2704200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2704205"],"award-info":[{"award-number":["2022YFC2704205"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272707"],"award-info":[{"award-number":["82272707"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772787"],"award-info":[{"award-number":["81772787"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82441045"],"award-info":[{"award-number":["82441045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072889"],"award-info":[{"award-number":["82072889"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bcp.2025.117069","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T18:50:15Z","timestamp":1750704615000},"page":"117069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["ATR-mediated phosphorylation of RIPK1 inhibits DNA damage-induced necroptosis"],"prefix":"10.1016","volume":"240","author":[{"given":"Shen-nan","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjia","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117069_b0005","article-title":"A comprehensive review of sensors of radiation-induced damage, radiation-induced proximal events, and cell death","author":"Saini","year":"2024","journal-title":"Immunol. Rev."},{"issue":"11","key":"10.1016\/j.bcp.2025.117069_b0010","article-title":"Targeting the DNA damage response in cancer","volume":"5","author":"Federica","year":"2024","journal-title":"MedComm. (2020)"},{"key":"10.1016\/j.bcp.2025.117069_b0015","article-title":"DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications","author":"Drew","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bcp.2025.117069_b0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","article-title":"Targeting replication stress in cancer therapy","volume":"22","author":"Da","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117069_b0025","article-title":"Advancements in programmed cell death research in antitumor therapy: a comprehensive overview","author":"Wei","year":"2024","journal-title":"Apoptosis"},{"issue":"5","key":"10.1016\/j.bcp.2025.117069_b0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","article-title":"A guide to cell death pathways","volume":"25","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117069_b0035","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41580-023-00623-w","article-title":"Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death","volume":"24","author":"Clucas","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2025.117069_b0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","article-title":"Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase","volume":"148","author":"Sun","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2025.117069_b0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","article-title":"Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3","volume":"54","author":"Wang","year":"2014","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2025.117069_b0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","article-title":"Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases","volume":"20","author":"Yuan","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bcp.2025.117069_b0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semcdb.2020.08.007","article-title":"25 years of research put RIPK1 in the clinic","volume":"109","author":"Liu","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117069_b0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cell.2011.02.023","article-title":"NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-alpha feedforward signaling","volume":"145","author":"Biton","year":"2011","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bcp.2025.117069_b0065","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2017.08.010","article-title":"A dual role of Caspase-8 in triggering and sensing proliferation-associated DNA damage, a key determinant of liver cancer development","volume":"32","author":"Boege","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2025.117069_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113947","article-title":"The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases","volume":"177","author":"Qin","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117069_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114542","article-title":"The multitargeted kinase inhibitor KW-2449 ameliorates cisplatin-induced nephrotoxicity by targeting RIPK1-mediated necroptosis","volume":"188","author":"Rui","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117069_b0080","article-title":"DNA damage-inducible transcript 3 positively regulates RIPK1-mediated necroptosis","author":"Ni","year":"2024","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.bcp.2025.117069_b0085","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1158\/1078-0432.CCR-22-1591","article-title":"Necroptosis-dependent immunogenicity of cisplatin: implications for enhancing the radiation-induced abscopal effect","volume":"29","author":"Luo","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"41","key":"10.1016\/j.bcp.2025.117069_b0090","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf6290","article-title":"ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation","volume":"7","author":"Yang","year":"2021","journal-title":"Sci. Adv."},{"issue":"22","key":"10.1016\/j.bcp.2025.117069_b0095","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1021\/acs.jmedchem.8b01187","article-title":"Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Kinase with Application as an Anticancer Agent","volume":"61","author":"Foote","year":"2018","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2025.117069_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12071525","article-title":"Regulation of RIPK1 phosphorylation: implications for inflammation, cell death, and therapeutic interventions","volume":"12","author":"Du","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bcp.2025.117069_b0105","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/s41467-019-09690-0","article-title":"Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation","volume":"10","author":"Dondelinger","year":"2019","journal-title":"Nat. Commun."},{"issue":"6652","key":"10.1016\/j.bcp.2025.117069_b0110","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.abn1725","article-title":"Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1","volume":"380","author":"Zhang","year":"2023","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bcp.2025.117069_b0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12943-024-01967-3","article-title":"Drug resistance in ovarian cancer: from mechanism to clinical trial","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2025.117069_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031223","article-title":"Synergism of AZD6738, an ATR inhibitor, in combination with belotecan, a camptothecin analogue, in chemotherapy-resistant ovarian cancer","volume":"22","author":"Hur","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2025.117069_b0125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/cr.2015.56","article-title":"Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics","volume":"25","author":"Koo","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2025.117069_b0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.isci.2019.06.019","article-title":"Role of Retinoic Acid Receptor-gamma in DNA Damage-Induced Necroptosis","volume":"17","author":"Kadigamuwa","year":"2019","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.bcp.2025.117069_b0135","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41418-020-00722-7","article-title":"The regulation of necroptosis by post-translational modifications","volume":"28","author":"Meng","year":"2021","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.bcp.2025.117069_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2017.05.003","article-title":"MK2 phosphorylates RIPK1 to prevent TNF-induced cell death","volume":"66","author":"Jaco","year":"2017","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.bcp.2025.117069_b0145","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ncb3608","article-title":"MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death","volume":"19","author":"Dondelinger","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117069_b0150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41467-017-00406-w","article-title":"Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis","volume":"8","author":"Geng","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bcp.2025.117069_b0155","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.bcp.2025.117069_b0160","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41571-024-00863-5","article-title":"Targeting ATR in patients with cancer","volume":"21","author":"Ngoi","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117069_b0165","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/nar\/gkad973","article-title":"ATR phosphorylates DHX9 at serine 321 to suppress R-loop accumulation upon genotoxic stress","volume":"52","author":"Liu","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"20","key":"10.1016\/j.bcp.2025.117069_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2023.09.003","article-title":"ATR promotes clearance of damaged DNA and damaged cells by rupturing micronuclei","volume":"83","author":"Joo","year":"2023","journal-title":"Mol. Cell"},{"issue":"18","key":"10.1016\/j.bcp.2025.117069_b0175","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1158\/0008-5472.CAN-22-0769","article-title":"And-1 coordinates with the FANCM complex to regulate fanconi anemia signaling and cisplatin resistance","volume":"82","author":"Zhang","year":"2022","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bcp.2025.117069_b0180","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s44318-024-00066-9","article-title":"ATR limits Rad18-mediated PCNA monoubiquitination to preserve replication fork and telomerase-independent telomere stability","volume":"43","author":"Chen","year":"2024","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.bcp.2025.117069_b0185","article-title":"ATR-dependent ubiquitin-specific protease 20 phosphorylation confers oxaliplatin and ferroptosis resistance","volume":"4","author":"Tang","year":"2023","journal-title":"MedComm. (2020)"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500334X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500334X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:06:45Z","timestamp":1777399605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522500334X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":37,"alternative-id":["S000629522500334X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117069","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATR-mediated phosphorylation of RIPK1 inhibits DNA damage-induced necroptosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117069"}}